What does Sun Pharma.Inds. do?
Sun Pharmaceutical Industries Ltd is a leading global specialty generic pharmaceutical company, the largest in India, with recent net sales of ₹129,588 Cr and a net profit of ₹21,499 Cr as of March 2025. It has a market cap of ₹414,857 Cr and key metrics include a P/E ratio of 36.00 and a dividend yield of 0.93%.
Overview:Sun Pharmaceutical Industries Ltd is a large-cap company in the Pharmaceuticals & Biotechnology industry, recognized as the fourth largest global specialty generic company.History:
Sun Pharmaceutical Industries Ltd was incorporated in 1993 and has since established itself as the largest Indian pharmaceutical company in the US. The latest quarterly results reported net sales and profit for March 2025.
Financial Snapshot:
Most recent Net Sales: 129,588 Cr (Quarterly Results - Mar 2025)
Most recent Net Profit: 21,499 Cr (Quarterly Results - Mar 2025)
Market-cap value: INR 414,857 Cr (Large Cap)
Key Metrics:
P/E: 36.00
Industry P/E: 37
Dividend Yield: 0.93%
Debt-Equity: -0.31
Return on Equity: 15.83%
Price to Book: 5.74
Contact Details:
Address: Sun Pharma Advanced Res.Centre, Tandalja Vadodara Gujarat : 390020
Phone: 91-265-6615500
Email: secretarial@sunpharma.com
Website: http://www.sunpharma.com
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
